Verapamil toxicity resulting from a probable interaction with telithromycin.
OBJECTIVE
To report a case of hypotension and bradyarrhythmia caused by verapamil toxicity in a patient prescribed telithromycin.


METHODS
A 76-year-old white woman receiving verapamil 180 mg/day for hypertension experienced a sudden onset of shortness of breath and weakness and was found to be profoundly hypotensive and bradycardic, with a systolic blood pressure of 50-60 mm Hg and a heart rate of 30 beats/min. She had been taking telithromycin 800 mg/day for 2 days previously for acute sinusitis. The patient was treated with crystalloids, vasopressors, and transvenous pacing. Approximately 72 hours after admission, her blood pressure and heart rate rapidly returned to normal, and she was discharged several days later.


CONCLUSIONS
Telithromycin is a known substrate of the CYP3A4 system, and several pharmacokinetic interactions can occur by displacement of other drugs from this system. Verapamil is metabolized through several cytochrome P450 isoenzyme systems. Although there are no previous reports of an interaction between these drugs, other possible causes for the patient's symptoms were excluded and the diagnosis of a probable interaction between verapamil and telithromycin leading to verapamil toxicity was made.


CONCLUSIONS
Telithromycin is a ketolide antibiotic approved for treatment of respiratory tract infections and acute sinusitis. The potential for clinically significant drug interactions should be considered before using this agent, especially in patients taking other drugs that are metabolized through the CYP3A system. Caution should be exercised when considering the use of this antibiotic in patients receiving verapamil.
Reed
Matthew
M
Iowa Methodist Medical Center, Des Moines, IA, USA.
Wall
Geoffrey C
GC
Shah
Niyati P
NP
Heun
James M
JM
Hicklin
Gregory A
GA
D000368:Aged; D001919:Bradycardia / Q000139:chemically induced / Q000378:metabolism; D004347:Drug Interactions / Q000502:physiology; D005260:Female; D006801:Humans; D007022:Hypotension / Q000139:chemically induced / Q000378:metabolism; D048628:Ketolides / Q000378:metabolism*; D014700:Verapamil / Q000009:adverse effects* / Q000378:metabolism*
D048628:Ketolides; D014700:Verapamil; C106791:telithromycin